Overview
A Closer Look at PAH Diagnosis, Screening, and Risk Assessment
Expert Perspectives
Click the "View Activity" button to view this activity.
View ActivityCME/CE is no longer available for this activity
In this short “How I Do It” vlog, expert faculty Dr. John Ryan, Director, Pulmonary Hypertension Comprehensive Care Center, University of Utah Hospital showcases personal experiences incorporating updated recommendations in clinical practice as well as diagnostic approaches, screening methods, and the importance of risk assessment. Upon completion of this activity, clinicians will be better able to incorporate effective screening techniques and appropriate diagnostic and risk assessment tools within clinical practice to improve outcomes for patients with PAH.
This activity is intended for pulmonologists, cardiologists, cardiopulmonologists, and other healthcare providers (MDs, PAs, and NPs) interested in treating patients with PAH.
The differential diagnosis of PAH is challenging, and diagnostic delays are common, leading to poorer patient outcomes. Clinicians require ongoing education on diagnostic algorithms and tools, patient populations appropriate for screening, and risk assessment methods to guide patient management. Upon completion of this activity, clinicians will be better able to apply appropriate diagnostic methods and risk assessment tools to enhance their recognition and management of PAH.
Upon completion of this activity, participants will be able to:
• Discuss recent changes to the clinical definition of PAH and their relevance to clinical practice
• Describe best practices for the use of algorithms and tools to improve diagnosis of PAH
• Apply risk assessment strategies to inform multidimensional approaches to the management of PAH
• Discuss recent changes to the clinical definition of PAH and their relevance to clinical practice
• Describe best practices for the use of algorithms and tools to improve diagnosis of PAH
• Apply risk assessment strategies to inform multidimensional approaches to the management of PAH
• Diagnostic tools and algorithm
• Screening
• Risk assessment
• Screening
• Risk assessment
Sponsored by the Academy for Continued Healthcare Learning (ACHL).
Supported by an educational grant from Actelion Pharmaceuticals US, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson.
1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.
2. Compatible with Windows PC and MAC (256 MB of RAM or higher)
3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher
4. Adobe Flash Player 12.0 (or higher). Click here to download Adobe Flash Player for free.
5. Adobe Reader to print certificate. Click here to download Adobe Reader for free.
6. Allow ActiveX controls to run on your computer: If the yellow strip appears on the top of your web browser while running the Webcast, right click on it and select Allow blocked contents to run.
Turn the Pop-up blocker off: On the Tools menu, point to Pop-up Blocker, and then click Turn Off Pop-up Blocker
John Ryan, MD, MB, BCh, BAO, MRCPI, FACC, FAHA
Director, Pulmonary Hypertension Comprehensive Care Center
Medical Director, Cardiovascular Medical Unit
University of Utah Hospital
Faculty Director of Cardiology Education
University of Utah School of Medicine
Salt Lake City, UT
Director, Pulmonary Hypertension Comprehensive Care Center
Medical Director, Cardiovascular Medical Unit
University of Utah Hospital
Faculty Director of Cardiology Education
University of Utah School of Medicine
Salt Lake City, UT
The Academy for Continued Healthcare Learning (ACHL) requires that the faculty participating in an accredited continuing education activity disclose all affiliations or other financial relationships (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any commercial supporters of the activity. All conflicts of interest have been mitigated prior to this activity.
The following financial relationships have been provided:
John Ryan, MD, MB, BCh, BAO, MRCPI, FACC, FAHA (Faculty)
Advisory Board: Bayer and Janssen PH
Consultant: Vertex
Speakers Bureau: Bayer, Janssen PH, United Therapeutics
Discussion of Off-Label, Investigational, or Experimental Drug/Device Use: None
ACHL staff members and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.
The content for this activity was developed independently of the commercial supporter. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher or grantor.
This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Recommendations involving clinical medicine in a continuing medical education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.
This CME/CE activity might describe the off-label, investigational, or experimental use of medications and/or devices that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. ACHL requires the speaker to disclose that a product is not labeled for the use under discussion.
This activity will take approximately 30 minutes to complete. To receive credit, participants are required to complete the pretest, view the online activity and complete the posttest and evaluation. To receive credit, 66% must be achieved on the posttest. A certificate will be immediately available. There is no fee to participate in the activity or for the generation of the certificate.
For questions, contact Michelle Forcier at mforcier@achlcme.org
The Academy for Continued Healthcare Learning is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Academy for Continued Healthcare Learning designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
(NOTE: Nurse practitioners may participate in this educational activity and earn a certificate of completing as AANP accepts AMA PRA Category 1 Credits™ through its reciprocity agreements.)
